These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35654277)

  • 1. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.
    Voigt RM; Wang Z; Brown JM; Engen PA; Naqib A; Goetz CG; Hall DA; Metman LV; Shaikh M; Forsyth CB; Keshavarzian A
    Neurobiol Dis; 2022 Aug; 170():105780. PubMed ID: 35654277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease.
    Chung SJ; Rim JH; Ji D; Lee S; Yoo HS; Jung JH; Baik K; Choi Y; Ye BS; Sohn YH; Yun M; Lee SG; Lee PH
    Nutrition; 2021 Mar; 83():111090. PubMed ID: 33418492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's Disease.
    He X; Qian Y; Xu S; Zhang Y; Mo C; Guo W; Yang X; Xiao Q
    J Parkinsons Dis; 2021; 11(3):1167-1176. PubMed ID: 33935107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.
    Chen SJ; Chen CC; Liao HY; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    J Parkinsons Dis; 2022; 12(4):1219-1230. PubMed ID: 35342048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
    Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
    Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy.
    Engen PA; Dodiya HB; Naqib A; Forsyth CB; Green SJ; Voigt RM; Kordower JH; Mutlu EA; Shannon KM; Keshavarzian A
    J Parkinsons Dis; 2017; 7(2):331-346. PubMed ID: 28234259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
    Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
    J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.
    Hoyles L; Jiménez-Pranteda ML; Chilloux J; Brial F; Myridakis A; Aranias T; Magnan C; Gibson GR; Sanderson JD; Nicholson JK; Gauguier D; McCartney AL; Dumas ME
    Microbiome; 2018 Apr; 6(1):73. PubMed ID: 29678198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
    Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.
    Wu G; Jiang Z; Pu Y; Chen S; Wang T; Wang Y; Xu X; Wang S; Jin M; Yao Y; Liu Y; Ke S; Liu S
    BMC Neurol; 2022 Jan; 22(1):13. PubMed ID: 34996385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
    Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
    Front Immunol; 2020; 11():574500. PubMed ID: 33042155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
    Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
    Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
    Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multi-omic Association Study of Trimethylamine N-Oxide.
    Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
    Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
    Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.